RepliCel Historical Valuation
| RP Stock | CAD 0.01 0.00 0.00% |
Some fundamental drivers such as market cap or RepliCel Life enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze RepliCel Life Sciences valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of RepliCel Life's future value.
RepliCel Life Working Capital |
|
RepliCel |
About RepliCel Valuation Data Analysis
Valuation is the financial process of determining what RepliCel Life is worth. RepliCel Life valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. RepliCel Life valuation ratios help investors to determine whether RepliCel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RepliCel with respect to the benefits of owning RepliCel Life security.
RepliCel Life Valuation Data Chart
Working Capital
The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.Enterprise Value
Enterprise Value (or EV) is usually referred to as RepliCel Life theoretical takeover price. In the event of an acquisition, an acquirer would have to take on RepliCel Life Sciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of RepliCel Life value than its market capitalization because it takes into account all of RepliCel Life Sciences existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from RepliCel Life's valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Enterprise Value is likely to climb to about 8.4 M in 2024, whereas Market Cap is likely to drop slightly above 3.7 M in 2024.
RepliCel Life valuation accounts Correlations
RepliCel Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RepliCel Life valuation accounts Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.1M | 6.2M | 7.5M | 3.2M | 3.9M | 3.7M | |
| Enterprise Value | 6.6M | 6.2M | 7.3M | 2.8M | 4.7M | 8.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.